In previous studies on breast cancer in general, the PD-L1 TC positivity rate ranged from 21.7% to 56.6%, indicating that the PD-L1 TC positivity rate is lower in ILC compared to breast cancer as a whole [53]. Here, CD274 is linked to breast carcinoma.